Official updates and announcements from GH Strategies, including firm milestones, partnerships, launches, and organisational developments.
There are moments in every industry when progress demands a new way of thinking. For GH Strategies, that moment arrived when the team looked beyond consulting and saw an even greater opportunity to educate, empower, and elevate the very professionals…
Every medicine, vaccine, and medical device carries the promise of better health, but also the responsibility of ensuring safety. In South Africa, the science of pharmacovigilance has become essential to maintaining that balance. It is the discipline that watches over…
Clinical trials depend on precision – not only in research design but also in how medicines, materials, and data move through an intricate global network. At the heart of every successful study lies a supply chain that functions flawlessly, ensuring…
Across Africa, the MedTech industry is undergoing a quiet transformation. What was once a fragmented field defined by regulatory hurdles and import dependency is becoming a space of innovation, standardization, and strategic growth. Behind this shift lies a growing realization:…
Across Africa, the pharmaceutical and MedTech sectors are entering a defining era. Markets are expanding, regulatory systems are maturing, and demand for high-quality, compliant products has never been greater. Yet, for many manufacturers and distributors, one challenge remains constant: navigating…
Some companies focus on ticking boxes. GH Strategies focuses on building legacies. From its earliest beginnings, GH Strategies set out to change the way pharmaceutical, medical device, and biotechnology companies in South Africa experience regulatory and quality consulting. What began…
In today’s life sciences and pharma sector, quality is not optional. It is the foundation upon which trust, safety, and market access are built. Nowhere is this more apparent than in the pharmaceutical and medical device industries, where regulatory scrutiny…